Lv2
110 积分 2020-12-31 加入
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
6天前
已完结
Current treatment landscape for patients with non-small cell lung cancer with common EGFR mutations
10天前
已完结
Discovery of Carbodiimide Warheads to Selectively and Covalently Target Aspartic Acid in KRASG12D
14天前
已完结
Antitumor activity of vebreltinib and characterization of clinicogenomic features in solid tumors with MET rearrangements
1个月前
已关闭
Cathepsin B: The dawn of tumor therapy
1个月前
已完结
Eph Receptors and Ephrins in Cancer Progression
2个月前
已完结
Targeting DNA damage response in pancreatic ductal adenocarcinoma: A review of preclinical and clinical evidence
2个月前
已完结
Co-targeting c-Met and DNA double-strand breaks (DSBs): Therapeutic strategies in BRCA-mutated gastric carcinomas
2个月前
已完结
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
2个月前
已完结
New Therapeutic Options for BRCA Mutant Patients
4个月前
已完结
皖公网安备34019202002308
